Android app Apple app link

Fulcrum Therapeutics, Inc. (FULC) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$4.84

north_east $0.29 (6.37%)
Day's range
$4.5
Day's range
$4.84

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/13/2024 H.C. Wainwright Andrew Fein $4.00 $3.44   16.28%
09/12/2024 RBC Capital Gregory Renza $4.00 $3.44   16.28%
09/12/2024 Stifel Nicolaus Dae Gon Ha downgraded Fulcrum Therapeutics $3.00 $3.55   -15.59%
09/12/2024 Bank of America Securities Tazeen Ahmad $2.00 $3.44   -41.86%
09/09/2024 Bank of America Securities Tazeen Ahmad $10.00 $8.61   16.21%
09/03/2024 RBC Capital Gregory Renza $15.00 $8.37   79.15%
05/20/2024 Cantor Fitzgerald Kristen Kluska $23.00 $7.55   204.64%
05/13/2024 Goldman Sachs Corinne Jenkins $15.00 $7.35   104.08%
05/13/2024 Stifel Nicolaus Dae Gon Ha $22.00 $7.48   194.12%
03/13/2024 RBC Capital Gregory Renza $14.00 $11.36   23.24%
11/08/2022 Piper Sandler Edward Tenthoff $18.00 $6.37   182.8%

Fulcrum Therapeutics, Inc. FAQ's

What analysts cover Fulcrum Therapeutics, Inc.?

Fulcrum Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, RBC Capital, Stifel Nicolaus, Bank of America Securities, Cantor Fitzgerald, Goldman Sachs in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.